DSE : IBNSINA

The IBN SINA Pharmaceutical Industry PLC

Pharmaceutical Preparations · Bangladesh

Last price 293.2 BDT (At close: Oct 29, 2026) · Market cap 9.16B

Latest research: IBN SINA Pharmaceutical financial analysis: 18% 9M sales growth, Mawna plant capex and record 77% dividend (Oct 2026) · IBN SINA Pharmaceutical: 9M FY2026 sales up 18% as the Mawna plant lifts capital work-in-progress to BDT 4.1bn, funded mostly with debt

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

The IBN SINA Pharmaceutical Industry PLC, together with its subsidiaries, engages in the production and sale of pharmaceutical drugs in Bangladesh and internationally. The company offers its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension; and sterile ophthalmic products, creams, ointments, gels, eye drops, and sachet. It also provides products in various therapeutic ...

Technical report: trend, RSI, support and resistance, charts

Reports